Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
BeiGene, Ltd. Initial Public Offering and NASDAQ Listing
Davis Polk advised the joint book-running managers and representatives of the underwriters in the $182.2 million initial…
Editas Medicine, Inc. $108.6 Million Initial Public Offering
Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the …
Novavax, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A…
Abbott Acquires Alere
Davis Polk is advising JP Morgan as financial adviser to Alere Inc. in connection with its $5.8 billion acquisition by…
Stryker Acquires Sage Products from Madison Dearborn Partners
Davis Polk is advising JP Morgan as financial adviser to Stryker Corporation in connection with its $2.775 billion…
Biotie acquisition by Acorda
Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc…
Ardelyx, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with an $86.2 million SEC-registered follow-on common stock…
Adamas Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $66.1 million SEC-registered common stock offering…
Cempra, Inc. Common Stock Offering
Davis Polk advised the underwriters in connection with the SEC-registered offering of 4,166,167 shares of common stock of…
Davis Polk Advises Affymetrix on Its Sale to Thermo Fisher
Davis Polk is advising Affymetrix, Inc. in connection with its sale to Thermo Fisher Scientific Inc. for a total equity…